Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sagimet Biosciences Inc.
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
October 16, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
October 11, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH
October 01, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference and Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit
September 12, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
September 04, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 14, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
August 01, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
BRNS
RCUS
SGMT
SNDX
Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat
June 10, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Presents Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat at EASL International Liver Congress 2024
June 06, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024
May 16, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 15, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024
May 07, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
May 06, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024
April 22, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat
March 27, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
March 25, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
IPSC
MIRM
RPHM
SGMT
Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 25, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
February 29, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
January 25, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
January 23, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
January 22, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
December 04, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit
November 28, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
November 22, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD - The Liver Meeting® 2023
October 24, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences To Present at the H.C. Wainwright 7th Annual NASH Investor Conference
October 18, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
September 27, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Sagimet Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 21, 2023
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Tickers
SGMT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit